CHARLES W. NEWHALL III - Director at SUPERNUS PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type: Individual
Role: Director
Issuer Symbol: SUPN on Nasdaq
All Insider Reports: All Insider Reports

CHARLES W. NEWHALL III - trading volume in the past year for SUPERNUS PHARMACEUTICALS, INC.

	Shares	%	Avg Price	Total $
Buys
Sells	-31,000	100%	$49.65	-$1,539,270
Net	-31,000	-100%		-$1,539,270

Holdings reported by CHARLES W. NEWHALL III for SUPERNUS PHARMACEUTICALS, INC.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	119,644	$1,552,979	$12.98	21 Nov 2025	Direct
Restricted Stock Unit	4,475	$177,658	$39.70	19 Feb 2025	Direct	Common Stock
Restricted Stock Units	0	$0	$39.70	22 Feb 2025	Direct	Common Stock
Director Stock Option (Right to Buy)	0			21 Nov 2025	Direct	Common Stock

Transactions reported by CHARLES W. NEWHALL III for SUPERNUS PHARMACEUTICALS, INC.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.